Peripheral arterial revascularization causing parallel increased activity of pro- and anti-inflammatory mediators

Area of Science:

• Vascular Surgery
• Immunology
• Interventional Cardiology

Background:

• Ischemia reperfusion injury (IRI) is a significant complication following peripheral arterial revascularization.
• The balance between pro-inflammatory and anti-inflammatory mediators plays a crucial role in IRI.
• Interleukin-6 (IL-6) is a key pro-inflammatory cytokine, while Interleukin-10 (IL-10) is a major anti-inflammatory cytokine.

Purpose of the Study:

• To investigate the dynamic interaction between IL-6 and IL-10 in patients undergoing peripheral arterial revascularization.
• To compare the inflammatory response in patients undergoing femoral angiography, angioplasty, and surgical bypass.

Main Methods:

• A cohort study involving three groups: femoral angiography, ilio/femoral angioplasty, and peripheral surgical bypass.
• Plasma samples collected pre-procedure and at 1 and 24 hours post-procedure.
• Enzyme-linked immunosorbent assay (ELISA) used to quantify IL-6 and IL-10 levels.

Main Results:

• Significantly elevated IL-6 levels were observed at 1 and 24 hours post-procedure in the surgical bypass group compared to angiography alone.
• Successful angioplasty also showed increased IL-6 levels at 24 hours.
• Elevated IL-10 levels were noted at 24 hours in the surgical bypass group, suggesting an anti-inflammatory response.

Conclusions:

• Peripheral surgical bypass and successful angioplasty induce early and sustained pro-inflammatory activity, as evidenced by increased IL-6.
• The observed rise in IL-10 levels indicates the body's attempt to counteract the inflammatory cascade.
• Understanding this cytokine interplay is vital for managing IRI in vascular interventions.